Nanotube Injector Enhances Mitochondrial Function for Regenerative Medicine
Researchers from Waseda University in Japan have developed a nanotube injector that significantly boosts mitochondrial performance through cytoplasmic transfer. This innovative system uses a thin gold membrane with vertically aligned nanotubes to transfer cytoplasmic contents, including mitochondria, between cell populations without damaging the cells. The nanotube injector allows for controlled and efficient cytoplasmic transfer, maintaining high cell viability and transfer efficiency. The technology is particularly relevant for regenerative medicine, where therapeutic cells often suffer from reduced metabolic activity. By enhancing mitochondrial function without genetic modification, the nanotube injector offers a new strategy to improve cell quality prior to transplantation. 
